Literature DB >> 24355258

Urinary biomarkers for the early diagnosis of retinopathy and nephropathy in type 1 diabetes mellitus: a "steady stream" of information using proteomics.

Emily K Sims1, Carmella Evans-Molina2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24355258      PMCID： PMC3951907          DOI： 10.1016/j.trsl.2013.11.013

Source DB:  PubMed          Journal:  Transl Res        ISSN： 1878-1810            Impact factor:   7.012


× No keyword cloud information.
  39 in total

1.  Worldwide increase in incidence of Type I diabetes--the analysis of the data on published incidence trends.

Authors:  P Onkamo; S Väänänen; M Karvonen; J Tuomilehto
Journal:  Diabetologia       Date:  1999-12       Impact factor: 10.122

Review 2.  Enhancing the predictive value of urinary albumin for diabetic nephropathy.

Authors:  M Luiza Caramori; Paola Fioretto; Michael Mauer
Journal:  J Am Soc Nephrol       Date:  2006-01-04       Impact factor: 10.121

3.  a-Series gangliosides mediate the effects of advanced glycation end products on pericyte and mesangial cell proliferation: a common mediator for retinal and renal microangiopathy?

Authors:  Elodie Masson; Lysiane Troncy; Daniel Ruggiero; Nicolas Wiernsperger; Michel Lagarde; Samer El Bawab
Journal:  Diabetes       Date:  2005-01       Impact factor: 9.461

Review 4.  Diabetic nephropathy: diagnosis, prevention, and treatment.

Authors:  Jorge L Gross; Mirela J de Azevedo; Sandra P Silveiro; Luís Henrique Canani; Maria Luiza Caramori; Themis Zelmanovitz
Journal:  Diabetes Care       Date:  2005-01       Impact factor: 19.112

5.  Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.

Authors:  John M Lachin; Saul Genuth; Patricia Cleary; Matthew D Davis; David M Nathan
Journal:  N Engl J Med       Date:  2000-02-10       Impact factor: 91.245

6.  Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus.

Authors: 
Journal:  JAMA       Date:  2002-05-15       Impact factor: 56.272

7.  Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial.

Authors:  Kasper Rossing; Peter Jacobsen; Lotte Pietraszek; Hans-Henrik Parving
Journal:  Diabetes Care       Date:  2003-08       Impact factor: 19.112

Review 8.  Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies.

Authors:  Thomas A Ciulla; Armando G Amador; Bernard Zinman
Journal:  Diabetes Care       Date:  2003-09       Impact factor: 19.112

Review 9.  Epidemiology of diabetic retinopathy and macular oedema: a systematic review.

Authors:  R Williams; M Airey; H Baxter; J Forrester; T Kennedy-Martin; A Girach
Journal:  Eye (Lond)       Date:  2004-10       Impact factor: 3.775

Review 10.  Hypoglycemia in diabetes.

Authors:  Philip E Cryer; Stephen N Davis; Harry Shamoon
Journal:  Diabetes Care       Date:  2003-06       Impact factor: 19.112
View more
  1 in total

Review 1.  Advances in Research on Diabetes by Human Nutriomics.

Authors:  Xinmin Ren; Xiangdong Li
Journal:  Int J Mol Sci       Date:  2019-10-29       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.